Status:
COMPLETED
An Evaluation of Probiotic in the Clinical Course of Patients With Colorectal Cancer
Lead Sponsor:
Dr. Liyana Zaharuddin
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Colorectal cancer (CRC) is the most common cancer for men and the second most common for women. Several studies have shown that gut microbiome may play a role in triggering intestinal inflammation tha...
Detailed Description
BACKGROUND: The study aimed to determine effects of probiotic consumption containing six viable microorganisms of 3g x 1010 Lactobacillus and Bifidobacteria strains for six months on clinical outcomes...
Eligibility Criteria
Inclusion
- 18 years and above.
- Diagnosed with colorectal cancer
- Planned for colorectal resection
Exclusion
- Received antibiotics 2 weeks prior to recruitment
- Consumed pro/pre/symbiotic product 2 weeks prior to recruitment,
- Patients with recurrent colorectal cancer
- Advanced metastasis
- Nursing or pregnant women
Key Trial Info
Start Date :
August 26 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 26 2018
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03782428
Start Date
August 26 2016
End Date
November 26 2018
Last Update
December 20 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.